Apokyn apomorphine hydrochloride regulatory update

Japan's Ministry of Health, Labor and Welfare approved an NDA from Kyowa for 30 mg subcutaneous Apokyn apomorphine to treat Parkinson's disease (PD). Apokyn has Orphan Drug designation in Japan. Kyowa...